TB Alternative Assets Ltd. grew its position in Rocket Lab Corporation (NASDAQ:RKLB - Free Report) by 508.5% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 320,703 shares of the rocket manufacturer's stock after buying an additional 268,000 shares during the period. Rocket Lab makes up about 4.6% of TB Alternative Assets Ltd.'s investment portfolio, making the stock its 7th largest holding. TB Alternative Assets Ltd. owned about 0.05% of Rocket Lab worth $22,347,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the company. Reflection Asset Management bought a new stake in shares of Rocket Lab during the fourth quarter valued at approximately $30,000. Meeder Asset Management Inc. bought a new position in Rocket Lab in the 2nd quarter valued at approximately $30,000. Highland Investment Advisors LLC purchased a new stake in Rocket Lab during the 2nd quarter valued at $30,000. NBH Bank purchased a new stake in Rocket Lab during the 2nd quarter valued at $30,000. Finally, Cherry Tree Wealth Management LLC purchased a new stake in Rocket Lab during the 2nd quarter valued at $32,000. Hedge funds and other institutional investors own 71.78% of the company's stock.
Rocket Lab Stock Down 6.6%
RKLB opened at $55.25 on Friday. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01. The firm has a 50 day moving average price of $69.50 and a 200-day moving average price of $84.29. Rocket Lab Corporation has a twelve month low of $37.57 and a twelve month high of $151.00. The stock has a market capitalization of $33.06 billion, a price-to-earnings ratio of -204.62 and a beta of 2.93.
Rocket Lab (NASDAQ:RKLB - Get Free Report) last issued its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.02). The company had revenue of $234.07 million during the quarter, compared to analysts' expectations of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. Equities research analysts forecast that Rocket Lab Corporation will post -0.20 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of research firms have commented on RKLB. Weiss Ratings reissued a "sell (d-)" rating on shares of Rocket Lab in a report on Thursday. Morgan Stanley reaffirmed an "overweight" rating on shares of Rocket Lab in a report on Wednesday, July 8th. TD Cowen reaffirmed a "buy" rating and set a $90.00 price objective on shares of Rocket Lab in a research report on Thursday. Berenberg Bank initiated coverage on Rocket Lab in a research report on Wednesday, September 2nd. They set a "buy" rating and a $83.00 price objective on the stock. Finally, Cantor Fitzgerald reiterated a "mixed" rating and issued a $122.00 price objective on shares of Rocket Lab in a report on Thursday. Three analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $104.05.
Get Our Latest Stock Analysis on RKLB
Insider Transactions at Rocket Lab
In other Rocket Lab news, insider Frank Klein sold 45,692 shares of the stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $69.63, for a total value of $3,181,533.96. Following the transaction, the insider directly owned 961,295 shares in the company, valued at approximately $66,934,970.85. This trade represents a 4.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Adam C. Spice sold 140,157 shares of the stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $70.82, for a total transaction of $9,925,918.74. Following the completion of the transaction, the chief financial officer owned 1,155,967 shares in the company, valued at $81,865,582.94. The trade was a 10.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 400,749 shares of company stock worth $26,964,474. Company insiders own 8.40% of the company's stock.
Key Rocket Lab News
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Rocket Lab reported record second-quarter revenue of approximately $234 million, up 62% year over year, supported by its Electron launch business, satellite operations and defense-related contracts. The company also reportedly has a backlog of about $2.4 billion. Rocket Lab Still Has a $2.4B Backlog While Neutron Waits
- Positive Sentiment: Several analysts remained constructive despite the setback. TD Cowen reaffirmed a Buy rating with a $90 price target, while Roth Capital maintained a Buy rating and a $110 target. These targets imply significant potential upside from recent levels. Stay Cool, Says Analyst About Rocket Lab Stock
- Neutral Sentiment: Rocket Lab’s broader business remains active, including Electron and HASTE launches, spacecraft components and government and defense programs. However, investors are increasingly focused on whether the company can execute its longer-term growth strategy while Neutron development continues.
- Negative Sentiment: Rocket Lab moved Neutron’s inaugural launch to 2027 from its prior fourth-quarter 2026 target. The delay followed a manufacturing flaw in a carbon-composite propellant-tank dome; the company plans additional repairs and testing before setting a launch date. Neutron is strategically important because management’s path to positive adjusted EBITDA depends heavily on the program’s progress. Rocket Lab pushes Neutron rocket's debut flight to 2027, shares fall
- Negative Sentiment: The setback heightened concerns about execution risk, cash burn and competition with SpaceX. KeyBanc and Clear Street reportedly reduced their price targets, while prior equity issuance to help fund the Iridium acquisition and continued insider selling added to the stock’s overhang. RKLB Stock Alert: What to Know as Rocket Lab Announces Neutron Launch Delay
About Rocket Lab
(
Free Report)
Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.
Rocket Lab's primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rocket Lab, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.
While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.